Source: Annual Congress 2004 - Clinical pathobiology of airway disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom). Time course of serum interleukin-6 during COPD exacerbations. Eur Respir J 2004; 24: Suppl. 48, 1957

Member's Comments

No comment yet.

Related content which might interest you: Time course of sputum and serum interleukin-6 during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 464s Year: 2005 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Time course of systemic inflammatory markers during acute exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 IL-18 in infectious exacerbations of COPD Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015